Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer

BACKGROUND: Despite the progress in the development of next‐generation sequencing (NGS), diagnostic PCR assays remain to be utilized in clinical routine due to their simplicity and low cost. Tests for 5′‐/3′‐end mRNA unbalanced expression can be used for variant‐independent detection of translocatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitiushkina, Natalia V., Romanko, Alexandr A., Preobrazhenskaya, Elena V., Tiurin, Vladislav I., Ermachenkova, Tatiana I., Martianov, Alexandr S., Mulkidjan, Rimma S., Sokolova, Tatiana N., Kholmatov, Maksim M., Bizin, Ilya V., Ivantsov, Alexandr O., Yatsuk, Olga S., Zaitseva, Olga A., Iyevleva, Aglaya G., Kuligina, Ekatherina Sh., Imyanitov, Evgeny N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468436/
https://www.ncbi.nlm.nih.gov/pubmed/35322575
http://dx.doi.org/10.1002/cam4.4686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468436/
https://www.ncbi.nlm.nih.gov/pubmed/35322575
http://dx.doi.org/10.1002/cam4.4686

Ejemplares similares